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Abstract
The SALMFamides are a family of neuropeptides that act as muscle relaxants in echinoderms. Two types of SALMFamides
have been identified: L-type (e.g. the starfish neuropeptides S1 and S2) with the C-terminal motif LxFamide (x is variable)
and F-type with the C-terminal motif FxFamide. In the sea urchin Strongylocentrotus purpuratus (class Echinoidea) there are
two SALMFamide genes, one encoding L-type SALMFamides and a second encoding F-type SALMFamides, but hitherto it
was not known if this applies to other echinoderms. Here we report the identification of SALMFamide genes in the sea
cucumber Apostichopus japonicus (class Holothuroidea) and the starfish Patiria miniata (class Asteroidea). In both species
there are two SALMFamide genes: one gene encoding L-type SALMFamides (e.g. S1 in P. miniata) and a second gene
encoding F-type SALMFamides plus one or more L-type SALMFamides (e.g. S2-like peptide in P. miniata). Thus, the ancestry
of the two SALMFamide gene types traces back to the common ancestor of echinoids, holothurians and asteroids, although
it is not clear if the occurrence of L-type peptides in F-type SALMFamide precursors is an ancestral or derived character. The
gene sequences also reveal a remarkable diversity of SALMFamide neuropeptides. Originally just two peptides (S1 and S2)
were isolated from starfish but now we find that in P. miniata, for example, there are sixteen putative SALMFamide
neuropeptides. Thus, the SALMFamides would be a good model system for experimental analysis of the physiological
significance of neuropeptide ‘‘cocktails’’ derived from the same precursor protein.
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Introduction
Secreted neuropeptides mediate intercellular neuronal signal-
ling and are involved in the regulation of diverse physiological
processes and behaviours [1]. To gain knowledge and un-
derstanding of how neuropeptide signalling systems have
evolved it is necessary to analyse neuropeptide systems in a wide
range of animal phyla. However, research on neuropeptides in
invertebrates has largely focused on protostomes, which include
model organisms such as Drosophila melanogaster (Phylum
Arthropoda), Caenorhabditis elegans (Phylum Nematoda) and
Aplysia californica (Phylum Mollusca) [2,3]. Much less is known
about neuropeptide systems in deuterostomian invertebrates,
which include invertebrate chordates (cephalochordates and
urochordates), hemichordates and echinoderms (starfish, sea
urchins, sea cucumbers). Nevertheless, research on these animals
has recently begun to provide important insights on the
evolution of neuropeptide signalling systems [4]. Furthermore,
the pentaradial body plan of adult echinoderms provides
a unique context for investigation of the physiological roles of
neuropeptide signalling systems [4,5].
The first echinoderm neuropeptides to be identified were the
SALMFamide neuropeptides S1 and S2, which were both isolated
from the starfish species Asterias rubens and Asterias forbesi on account
of their cross-reactivity with antibodies to the molluscan
FMRFamide-like neuropeptide pQDPFLRFamide [6,7]. S1 is
a C-terminally amidated octapeptide with the amino acid
sequence Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2 (GFNSALM-
Famide) and S2 is a C-terminally amidated dodecapeptide with
the amino acid sequence Ser-Gly-Pro-Tyr-Ser-Phe-Asn-Ser-Gly-
Leu-Thr-Phe-NH2 (SGPYSFNSGLTFamide). Comparison of the
sequences of S1 and S2 revealed that both peptides have the C-
terminal motif FNSxLxFamide (where x is variable), suggesting
that S1 and S2 may have evolved as a consequence of gene
duplication or intragenic DNA duplication [6].
Subsequently, antibodies to pQDPFLRFamide were also used
to monitor purification of SALMFamide neuropeptides from
another echinoderm species, the sea cucumber Holothuria glaberrima
[8]. Two structurally related neuropeptides were identified: Gly-
Phe-Ser-Lys-Leu-Tyr-Phe-NH2 (GFSKLYFamide) and Ser-Gly-
Tyr-Ser-Val-Leu-Tyr-Phe-NH2 (SGYSVLYFamide). Further-
more, comparison of the sequences of these sea cucumber
neuropeptides with the starfish SALMFamides S1 and S2 revealed
a shared C-terminal motif: SxLxFamide (where x is variable).
Thus, it was postulated that this motif may be a defining
characteristic of a family of SALMFamide neuropeptides in the
phylum Echinodermata [8].
The discovery of SALMFamides enabled the first investigations
of the physiological roles of identified neuropeptides in echino-
derms. In vitro studies revealed that S1 and S2 both cause
relaxation of cardiac stomach, tube foot and apical muscle
preparations from A. rubens, but with S2 being more potent/
effective than S1 [9,10,11]. Furthermore, the relaxing effects of S1
or S2 in vivo cause eversion of the cardiac stomach, indicating that
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S1 and/or S2 may mediate physiological control of stomach
eversion during feeding in starfish [10]. Consistent with this
notion, antibodies to S1 and S2 reveal immunoreactive nerve
fibres in close association with the muscle layer of the cardiac
stomach [12]. Likewise, S1- and/or S2-immunoreactive fibres are
also present in the tube feet and apical muscle, indicative of
a general role for these peptides as regulators of muscle relaxation
in starfish [13]. Furthermore, the two SALMFamides identified in
H. glaberrima also cause relaxation of intestinal and longitudinal
body wall muscle preparations in this species [14]. Thus, it appears
that SALMFamides may act as muscle relaxants throughout the
phylum Echinodermata [15].
The muscle-relaxing effect of SALMFamide neuropeptides was
also observed when longitudinal body wall muscle and intestine
preparations were used as bioassays to screen for myoactive
peptides in the sea cucumber Apostichopus japonicus. A total of twenty
myoactive peptides were identified but only two of these were
found to cause muscle relaxation: GYSPFMFamide and
FKSPFMFamide [16]. It was clear that these two peptides are
structurally related to the SALMFamide neuropeptides previously
identified H. glaberrima - GFSKLYFamide and SGYSVLYFamide.
However, the presence in the A. japonicus peptides of a phenylal-
anine (F) residue in the position occupied by a leucine (L) residue
in the H. glaberrima peptides broadened the structural motif of
SALMFamide neuropeptides to Sx(L/F)xFamide. It remained
unclear though whether the identification of SALMFamides in
different sea cucumber species that either have a SxLxFamide
motif (L-type SALMFamides) or have a SxFxFamide motif (F-type
SALMFamides) reflects species-specific variation in SALMFamide
structure or whether L-type and F-type SALMFamides coexist in
echinoderm species. This issue was resolved with identification of
two SALMFamide genes in the sea urchin Strongylocentrotus
purpuratus – one gene that encodes a precursor protein comprising
seven putative F-type SALMFamide neuropeptides (SpurS1–
SpurS7) and another gene that encodes a precursor protein
comprising two putative L-type SALMFamide neuropeptides
(SpurS8– SpurS9) [17,18]. This discovery demonstrated that L-
type and F-type SALMFamides do both occur in an echinoderm
species but are derived from different precursor proteins. Recently,
however, a gene encoding SALMFamide neuropeptides in the sea
cucumber A. japonicus has been identified [19], revealing a pre-
cursor protein that comprises eight putative neuropeptides,
including the two F-type SALMFamides originally identified in
this species on account of their muscle relaxing effects (GYSPFM-
Famide and FKSPFMFamide), as well as two L-type SALMFa-
mides that share sequence similarity with the two L-type
SALMFamides originally isolated from H. glaberrima. Thus, L-type
and F-type SALMFamides coexisting in an echinoderm species
can also be derived from the same precursor.
A number of questions remain to be answered with regard to
the phylogenetic distribution and evolution of SALMFamide
neuropeptides in the Phylum Echinodermata. Does the existence
of a gene in A. japonicus encoding a precursor comprising both L-
type and F-type SALMFamides reflect a characteristic of the
common ancestor of the Holothuroidea (sea cucumbers) and the
Echinoidea (sea urchins), two sister classes within the phylum
Echinodermata? If it does, then the existence in S. purpuratus of two
genes encoding precursors comprising either L-type or F-type
SALMFamides could be explained by duplication of a gene
encoding the putative ancestral-type precursor followed by
specialisation as either L-type or F-type precursors. However, it
is noteworthy that the SALMFamide precursor previously
identified in A. japonicus [19] is quite similar to the F-type
SALMFamide precursor in S. purpuratus [17] in at least two
respects. Firstly, with respect to the number of putative neuropep-
tides derived from the precursors; the S. purpuratus precursor
contains seven putative neuropeptides and the A. japonicus pre-
cursor contains eight putative neuropeptides. Secondly, whilst the
A. japonicus precursor does contain putative L-type SALMFamides,
it is predominantly an F-type SALMFamide precursor with five
out of eight putative neuropeptides having an F-type motif.
Because of this similarity between the previously reported A.
japonicus SALMFamide precursor and the S. purpuratus F-type
SALMFamide precursor, we postulate that there may be a second
SALMFamide precursor in A. japonicus that is related to the L-type
SALMFamide precursor in S. purpuratus.
Another issue that remains to be addressed is the phyloge-
netic distribution of F-type SALMFamides. Thus far, F-type
SALMFamides have only been identified in sea cucumbers and
sea urchins. Do F-type SALMFamides also exist in other
echinoderm classes – the Ophiuroidea (brittle stars), the
Asteroidea (starfish) and the Crinoidea (sea lilies, feather stars)?
Lastly, is the diversity of SALMFamides that have been
identified by analysis of gene sequences in a sea urchin species
(nine SALMFamides in S. purpuratus) [18] and a sea cucumber
species (eight SALMFamides in A. japonicus) [19] indicative of
the number of SALMFamides that exist in other echinoderms?
Evidence that this may be the case, at least in starfish, was
provided by the purification and sequencing of four SALMFa-
mides from nerve cord extracts of Marthasterias glacialis. Thus, in
addition to S1 and an S2-like peptide (SGPYSMTSGLTFa-
mide; MagS2), two other SALMFamides were identified: MagS3
(AYHSALPFamide) and MagS4 (AYQTGLPFamide) [20]. De-
finitive determination of the number of SALMFamides that
exist in a starfish species, however, will require sequencing of
the gene(s) encoding these peptides.
To address the questions outlined above, we have investigated
the occurrence of an L-type SALMFamide gene in A. japonicus
and have searched for SALMFamide genes in the starfish
species Patiria miniata. The data obtained provide important new
insights on the phylogenetic distribution, evolution and struc-
tural diversity of SALMFamide neuropeptides in the phylum
Echinodermata.
Methods
Apostichopus Japonicus
To search for a second SALMFamide precursor in A. japonicus,
the S. purpuratus L-type SALMFamide precursor was submitted as
a query in a tBLASTn search of 29,666 A. japonicus contigs, which
were downloaded from the supporting information section
(Dataset S1) of an online paper by Du et al. [21] available from
the PloSONE website (http://www.plosone.org/article/
info%3Adoi%2F10.1371%2Fjournal.pone.0033311). BLAST
searches were performed using SequenceServer software (http://
www.sequenceserver.com/), which is freely available to academic
users [22].
Patiria Miniata
To search for SALMFamide genes in the starfish Patiria miniata,
genome sequence data generated by the Baylor College of
Medicine Human Genome Sequencing Center were downloaded
from NCBI (http://0-www.ncbi.nlm.nih.gov.ilsprod.lib.neu.edu/
nuccore/399761416). Sequence data were downloaded as 179,756
contigs (AKZP01000001 - AKZP01179756) and as 21,465
scaffolds (JH768608 - JH790072) and then BLAST searches of
the sequence data were performed using SequenceServer software.
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Comparative Analysis of the Sequences of SALMFamide
Precursor Proteins
The online multiple sequence alignment tool Clustal Omega
(http://www.ebi.ac.uk/Tools/msa/clustalo/; with default param-
eters) was used to enable comparative analysis of the sequences of
echinoderm SALMFamide precursor proteins.
Results and Discussion
Identification of a Second SALMFamide Gene in
Apostichopus japonicus
When the protein sequence of the S. purpuratus L-type
SALMFamide precursor [18] was submitted as a query in
a tBLASTn search of A. japonicus isotig sequence data, the top
two hits were isotig 08429 (isogroup 02114; 3072 bases) and
isotig 08430 (isogroup 02114; 2838 bases). Comparative analysis
of the sequences of isotigs 08429 and 08430 revealed that they
share 99% nucleotide sequence identity and encode the same
protein (see below), with the only major difference between
them being that 08429 has a 39 extension with respect to
08430. Therefore, the sequence of the longer isoform (08429) is
shown in Figure 1.
Analysis of the sequences of isotigs 08429 and 08430 revealed
that they encode a 176-residue protein comprising an N-terminal
signal peptide and three putative L-type or L-type-like SALMFa-
mide neuropeptides bounded by putative dibasic (KR, KK)
endopeptidase cleavage sites (Figure 1). All three putative
neuropeptides have a C-terminal glycine residue, which is likely
to be a substrate for amidation [23]. The first putative
neuropeptide is a 17-residue peptide, the second neuropeptide is
a 14-residue peptide and the third neuropeptide is an 11-residue
peptide. The 14-residue peptide (TRSRSMFGNTALPFamide)
has the canonical L-type SALMFamide C-terminal LxFamide
motif. In the 17-residue peptide (VVSRAWSPLVGQTGIAFa-
mide) the leucine residue that characterizes L-type SALMFamides
is replaced by the structurally related amino acid isoleucine and in
this respect it is similar to the S. purpuratus L-type-like SALMFa-
mide SpurS8, which has the C-terminal sequence IHFamide [18].
The C-terminal sequence of the 11-residue peptide
(MGFTGNTGILLamide) is ILLamide, which is unusual because
a leucine (L) residue replaces the C-terminal phenylalanine (F)
residue that is characteristic of both L-type and F-type
SALMFamide neuropeptides. Interestingly, a peptide (FKSSFY-
Lamide) with the same modification is a predicted product of the
SALMFamide precursor previously identified in A. japonicus, which
is a precursor of both F-type and L-type SALMFamides [19].
Identification of a Gene in Patiria miniata that Encodes S1
and Other L-type SALMFamides
To search for a gene encoding the starfish neuropeptide S1
and/or structurally related neuropeptides, a P. miniata contig
dataset was queried (using tBLASTn) with KRGFNSALMFGKR,
an S1-containing amino acid sequence bounded by dibasic
cleavage sites. A single hit was identified (contig 39135; 29729
bases) and analysis of the sequence of contig 39135 revealed that it
contains an open reading frame encoding a 150-residue poly-
peptide sequence comprising S1 and six other putative L-type
SALMFamide neuropeptides. Because the 150-residue sequence
lacked an N-terminal signal peptide it was inferred that the gene
must have an additional exon or exons that encode the N-terminal
signal peptide. To facilitate identification of this putative exon, the
150-residue sequence was submitted as a query in a tBLASTn
search of the P. miniata genome scaffold dataset, which revealed
that the coding sequence for the 150-residue polypeptide is in
scaffold 1914 (55,595 bases). The sequence of scaffold 1914 was
then analysed using gene prediction tools (GenScan: http://genes.
mit.edu/GENSCAN.html; Augustus: http://bioinf.uni-greifswald.
de/augustus/submission) but the predicted proteins incorporating
the 150-residue sequence containing SALMFamide neuropeptides
did not have an N-terminal signal peptide sequence. Therefore,
the region of scaffold 1914 located 59 to the exon encoding the
150-residue sequence containing SALMFamide neuropeptides was
analysed systematically to identify an open reading frame that
encodes a polypeptide with an N-terminal signal peptide. Using
this strategy an exon encoding a signal peptide-containing
polypeptide was successfully identified upstream from the
SALMFamide-encoding exon, separated by an 18,144 base intron.
Thus, the predicted precursor of S1 and other L-type SALMFa-
mides in P. miniata is a 174-residue protein with an 18-residue N-
terminal signal peptide (Figure 2).
Identification of a Gene in Patiria miniata that Encodes F-
type SALMFamides and an S2-like Peptide
As the SALMFamide precursor comprising S1 and other L-type
SALMFamides (Figure 2) does not contain S2 or an S2-like
peptide, it was deduced that there might be a second SALMFa-
mide precursor in P. miniata. To search for this putative gene, the
amino acid sequence of the P. miniata S1 precursor was submitted
as a query in a tBLASTn search of the P. miniata contig dataset.
This revealed the existence of a second SALMFamide gene on
contig 45038 (27003 bases). Analysis of the sequence of contig
45038 using the gene prediction tool GenScan revealed the
presence of a gene comprising two exons (separated by a 3318 base
intron), with the first exon encoding a 38-residue sequence with an
N-terminal signal peptide and the second exon encoding a 220
residue sequence comprising a putative S2-like peptide
(SNGPYSMSGLRSLTFamide) and eight putative F-type or F-
type-like SALMFamide neuropeptides (Figure 3). Thus, in P.
miniata an S2-like L-type SALMFamide neuropeptide is derived
from a 258-residue precursor of F-type SALMFamides.
The Evolution of SALMFamide Neuropeptide Precursors
The identification of SALMFamide neuropeptide precursors in
species from three different echinoderm classes has provided the
first opportunity to investigate the evolution of SALMFamide
neuropeptides, informed by current thinking on the phylogenetic
relationships of the five extant echinoderm classes [24]. There is
consensus that crinoids are basal with respect to the four other
extant classes, with a divergence time estimated at , 509 million
years ago. There is also consensus that echinoids and holothurians
are sister groups. However, there is conflicting evidence with
respect to the position of the asteroids and ophiuroids and
evidence for all three possible groupings (Figure 4A) has been
obtained [24]. This difficulty in resolving relationships between the
echinoid/holothurian, asteroid and ophiuroid clades is attributed
to their divergence over a relatively short period of geological time
(, 5 million years) 475–480 million years ago [24]. Nevertheless,
regardless of which of the alternate phylogenies (Figure 4A) is
correct, with the sequence data now available it is possible to draw
several conclusions on the phylogenetic distribution and evolution
of SALMFamide precursors.
In Figure 4B the three pairs of SALMFamide precursors that
have been identified in species representing three echinoderm
classes are shown in a phylogenetic schematic. What is immedi-
ately apparent from this diagram is that in each class (as
represented by one species) there are two types of SALMFamide
precursor: Firstly, a precursor that is exclusively comprised of L-
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type peptides or L-type-like peptides. Secondly, a precursor that is
either exclusively comprised of F-type peptides (as in the echinoid
species) or a precursor that is largely comprised of F-type peptides
or F-type-like peptides together with one or more L-type or L-
type-like peptides (as in the holothuroid and asteroid species). We
can infer from this that it is likely that the common ancestor of
echinoids, holothurians and asteroids would have had two
SALMFamide genes: one encoding only L-type SALMFamides
(an ‘‘L-type SALMFamide precursor’’) and a second encoding
exclusively or largely F-type SALMFamides (an ‘‘F-type SAL-
MFamide precursor’’). What remains uncertain based on the data
available is whether the presence of L-type peptides in F-type
SALMFamide precursors reflects the ancestral condition or
whether it is a derived condition. The former requires invoking
loss of L-type peptides in F-type SALMFamide precursors in only
one lineage, the echinoids, whereas the latter requires invoking
independent acquisition of L-type peptides in the F-type
SALMFamide precursors of two lineages, the holothurians and
the asteroids. It is not possible draw firm conclusions based on the
data currently available but further insight on this issue will be
obtained if SALMFamide genes are identified in an ophiuroid
species. Moreover, as the most basal of the five extant classes [24],
it will be especially interesting to identify a SALMFamide gene or
genes in a crinoid species. Thus, does the occurrence of the two
SALMFamide gene types date back to the common ancestor of all
extant echinoderm classes? Alternatively, do crinoids have only
a single L/F-type SALMFamide gene?
Clearly there is much still to be learnt about the evolutionary
history of SALMFamide genes. However, even with data from just
three echinoderm species, some general characteristics of SAL-
MFamide genes/precursors are apparent. For example, it is
evident from the two species where genome sequence data are
available (S. purpuratus and P. miniata) that SALMFamide genes
comprise two protein-coding exons: the first exon encoding the
predicted N-terminal signal peptide and the second exon encoding
all of the putative neuropeptide products of the precursor protein
[18]. It is also evident that in all three echinoderm species the L-
type SALMFamide precursor protein is shorter than the F-type
SALMFamide precursor protein (Figure 4), which may also
therefore be a feature of SALMFamide precursors in other
echinoderms. In addition to these general characteristics of
SALMFamide precursors, more detailed comparative analysis of
the sequence data provides further insights on the structural
characteristics and diversity of SALMFamide neuropeptides and
the organisation of the precursor proteins that they are derived
from, as discussed below.
Figure 1. Apostichopus japonicus L-type SALMFamide precursor. The cDNA sequence (lowercase, 3072 bases) of isotig 08429, which encodes
an L-type SALMFamide precursor protein (bold uppercase, 176 amino acid residues) is shown. The predicted signal peptide is shown in blue and the
three putative SALMFamide neuropeptides are shown in red flanked by putative dibasic cleavage sites (KR or KK) shown in green. The asterisk shows
the position of the stop codon.
doi:10.1371/journal.pone.0059076.g001
Figure 2. Patiria miniata L-type SALMFamide precursor. The sequence of a gene (lowercase) in P. miniata that encodes an L-type SALMFamide
precursor protein (bold uppercase, 174 amino acid residues) is shown. The majority of a large intron that separates the two exons is not shown
(dashed line) but the 59 and 39 regions are shown, including the respective splice sites gt and ag, which are highlighted in bold. The predicted signal
peptide of the precursor protein is shown in blue and the seven putative SALMFamide neuropeptides are shown in red flanked by putative dibasic
cleavage sites (KR or RR) shown in green. The asterisk shows the position of the stop codon.
doi:10.1371/journal.pone.0059076.g002
Evolution and Diversity of SALMFamides
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Comparative Analysis of the Sequences of L-type
SALMFamide Precursors and Putative SALMFamides
Derived from L-type SALMFamide Precursors
A Clustal Omega alignment of L-type SALMFamide precursors
from S. purpuratus, A. japonicus and P. miniata is shown in Figure 5A
and regions of the precursor proteins that correspond with
putative neuropeptides that are aligned in all three species or that
are aligned between P. miniata and S. purpuratus or A. japonicus are
labelled Align L1, Align L2 and Align L3. The logic here is that
neuropeptides that only align between S. purpuratus and A. japonicus
may be unique to the echinoid/holothurian clade whereas
neuropeptides that align in all three species or align between P.
miniata and S. purpuratus or A. japonicus could be conserved features
of an ancestral L-type SALMFamide precursor.
The putative neuropeptides labelled by Align L1 are between
13 and 17 residues in length (excluding the C-terminal glycine
residues that are putative amidation substrates). Furthermore, it
is noteworthy that the putative neuropeptides from A. japonicus
and P. miniata in Align L1 both have either one or two proline
residues, which due to their conformational rigidity may
strongly influence secondary structure characteristics of these
peptides [25].
The putative neuropeptides labelled by Align L2 are between
7 and 14 residues in length. Furthermore, it is noteworthy that
the putative neuropeptides from A. japonicus and P. miniata in
Align L2 both have the C-terminal sequence TALPFamide.
Align L3 labels putative neuropeptides located in the C-terminal
regions of the L-type SALMFamide precursors from A. japonicus
and P. miniata, which are 11 and 8 residues in length, respectively.
The A. japonicus peptide in Align L3 (MGFTGNTGILLamide) is
unusual in having the C-terminal sequence ILLamide but in
common with the P. miniata peptide in Align L3 (GYHTGLPFa-
mide), it has a Thr-Gly (TG) motif.
Based on the multiple sequence alignment in Figure 5A and the
observations above, we speculate that an ancestral L-type
SALMFamide precursor may have comprised three L-type
SALMFamides corresponding with Align L1, Align L2 and Align
L3 in Figure 5A. Thus, the A. japonicus L-type SALMFamide
precursor conforms most closely with this hypothetical ancestral
precursor. Accordingly, we speculate that in echinoids (S.
purpuratus) the Align L3 peptide was lost and in asteroids multiple
intragenic duplication events gave rise to the seven L-type
SALMFamides found in the P. miniata L-type SALMFamide
precursor.
Fig. 5B shows a C-terminal alignment of all of the putative
neuropeptides derived from the L-type SALMFamide precursors
in S. purpuratus, A. japonicus and P. miniata, with colour-coding
according to amino acid properties. What is apparent is that there
are clusters of hydrophobic and hydrophilic residues, with 3–4
hydrophobic residues at the C-terminus preceded by a cluster of
Figure 3. Patiria miniata F-type SALMFamide precursor. The sequence of a gene (lowercase) in P. miniata that encodes an F-type SALMFamide
precursor protein (bold uppercase, 258 amino acid residues) is shown. The majority of a large intron that separates the two exons is not shown
(dashed line) but the 59 and 39 regions are shown, including the respective splice sites gt and ag, which are highlighted in bold. The predicted signal
peptide of the precursor protein is shown in blue and the nine putative SALMFamide neuropeptides are shown in red flanked by putative dibasic
cleavage sites (KR or RR) shown in green. The asterisk shows the position of the stop codon.
doi:10.1371/journal.pone.0059076.g003
Evolution and Diversity of SALMFamides
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2–5 hydrophilic residues. Furthermore, it is noteworthy that basic
residues, if present, only occur in the N-terminal regions of
putative neuropeptides.
Comparative Analysis of the Sequences of F-type
SALMFamide Precursors and Putative SALMFamides
Derived from F-type SALMFamide Precursors
A Clustal Omega alignment of F-type SALMFamide precursors
from S. purpuratus, A. japonicus and P. miniata is shown in Figure 6A
and putative neuropeptides that are aligned in all three species or
that are aligned between P. miniata and S. purpuratus or A. japonicus
are labelled Align F1– Align F7. As highlighted above for L-type
SALMFamide precursors, the logic of this is that neuropeptides
that only align between S. purpuratus and A. japonicus may be unique
to the echinoid/holothurian clade whereas neuropeptides that
align in all three species or align between P. miniata and S.
purpuratus or A. japonicus could be conserved features of an ancestral
F-type SALMFamide precursor.
The putative neuropeptides in Align F1 are located in the N-
terminal region of the A. japonicus and P. miniata F-type
SALMFamide precursors and are F-type-like SALMFamides with
the C-terminal sequences VTYamide and YPYamide, which share
a C-terminal Yamide motif. Interestingly, both peptides contain
one or two proline residues and in this respect they are similar to
the putative neuropeptides in Align L1 of the L-type SALMFa-
mide precursors. Accordingly, the presence of these proline
residues may influence secondary structure characteristics of these
peptides [25].
The putative neuropeptides in Align F2 are conserved in all
three species and have the canonical F-type SALMFamide C-
terminal motif FxFamide. Furthermore, two of the neuropeptides
have two proline residues: PPVTTRSKFTFamide in S. purpuratus
and TDVPGRPSGFVFamide in A. japonicus. In this respect they
are similar to peptides in Align F1 (Figure 6A) and in Align L1
(Figure 5A), with a concordant potential for the proline residues to
influence secondary structure characteristics of these peptides [25].
The putative neuropeptides in Align F3 are present in A.
japonicus (ARYSPFTFamide) and P. miniata
(SNGPYSMSGLRSLTFamide) but not S. purpuratus. Interestingly,
the P. miniata peptide is an L-type and S2-like SALMFamide,
which shares a C-terminal TFamide motif with the A. japonicus F-
type peptide.
The putative neuropeptides in Align F4 are present in S.
purpuratus and P. miniata but not in A. japonicus and they both have
the canonical F-type SALMFamide C-terminal motif FxFamide.
The putative neuropeptides in Align F5 are represented in all
three species but, interestingly, the A. japonicus peptide is an L-type
SALMFamide (GGYSALYFamide), whilst the neuropeptides in S.
purpuratus and P. miniata are both canonical F-type SALMFamides
with a C-terminal FxFamide motif.
The putative neuropeptides in Align F6 are represented in all
three species and are canonical F-type SALMFamides with a C-
terminal FxFamide motif.
Figure 4. Phylogenetic analysis of SALMFamide precursors in echinoderms. A. Echinoderm phylogeny. The basal position of crinoids and
the sister group status of echinoids and holothurians is widely accepted but there is conflicting evidence with respect to the phylogenetic position of
asteroids and ophiuroids [24]; therefore the three possible echinoderm phylogenies are shown in Ai, Aii and Aiii. B. Phylogenetic diagram showing
the occurrence and organisation of SALMFamide precursors in species representing three echinoderm classes: the Echinoidea (Strongylocentrotus
purpuratus; Sp), the Holothuroidea (Apostichopus japonicus; Aj) and the Asteroidea (Patiria miniata; Pm). Signal peptides are shown in blue and dibasic
or monobasic cleavage sites are shown in green. L-type SALMFamides with the canonical C-terminal LxFamide motif are shown in red and peptides
that are ‘‘L-type-like’’ (e.g. MGFTGNTGILLamide in A. japonicus, where the L and F are replaced by I and L, respectively) are shown in red with hatched
shading. Likewise, F-type SALMFamides with the canonical C-terminal FxFamide motif are shown in yellow and peptides that are ‘‘F-type-like’’ (e.g.
ADLFRSYAFamide in P. miniata, where one of the F residues is replaced by Y) are shown in yellow with hatched shading. In each species (class) there
are two types of SALMFamide precursor: Firstly, a precursor that is exclusively comprised of L-type peptides or L-type-like peptides. Secondly,
a precursor that is either exclusively comprised of F-type peptides (Sp) or a precursor that is largely comprised of F-type peptides or F-type-like
peptides together with one or more L-type or L-type-like peptides (Aj and Pm).
doi:10.1371/journal.pone.0059076.g004
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The putative neuropeptides in Align F7 are represented in all
three species and the S. purpuratus and P. miniata peptides have
a canonical F-type SALMFamide FxFamide motif. The A. japonicus
peptide in Align F7 is unusual in having a C-terminal leucine
residue (FKSSFYLamide) and it is noteworthy that it has in
common with the P. miniata peptide (SGLSSFTFamide) a Ser-Ser
motif.
Based on the multiple sequence alignment in Figure 6A and the
observations above, we speculate that an ancestral F-type
SALMFamide precursor may have comprised seven SALMFa-
mide neuropeptides corresponding with Align F1– Align F7 in
Figure 6A. Subsequently, lineage specific intragenic duplication
events may have given rise to the additional neuropeptides that fall
outside regions labeled by Align F1 to Align F7. An important
observation from the data shown in Figure 6A and discussed above
is that L-type SALMFamides are not aligned in the P. miniata and
A. japonicus F-type SALMFamide precursors. This suggests that L-
type SALMFamides may have arisen independently in the F-type
SALMFamide precursors of asteroids (P. miniata) and holothurians
(A. japonicus).
Fig. 6B shows a C-terminal alignment of all of the putative
neuropeptides derived from the F-type SALMFamide precursors
in S. purpuratus, A. japonicus and P. miniata, with colour-coding
according to amino acid properties. As with the peptides derived
from L-type SALMFamide precursors (Figure 5B), the 3–4
residues located at the C-terminus of the peptides are pre-
dominantly hydrophobic. However, by comparison with peptides
derived from L-type SALMFamide precursors, hydrophilic
residues are more prevalent at the penultimate amino acid
position. In addition, basic and acidic residues are generally more
prevalent than in peptides derived from L-type SALMFamide
precursors.
Figure 5. Comparative analysis of L-type SALMFamide precursors and putative SALMFamides derived from L-type SALMFamide
precursors. A. Multiple sequence alignment of L-type SALMFamide precursors from Strongylocentrotus purpuratus (Sp), Apostichopus japonicus (Aj)
and Patiria miniata (Pm). The symbol * labels the positions of residues that are identical in all three sequences, whilst the symbols : and. label the
positions of strongly and weakly conserved residues, respectively. Putative neuropeptides that are aligned in all three sequences or that are aligned
in the Pm sequence and the Sp or Aj sequences are labelled: Align L1, Align L2 and Align L3. B. Comparison of the C-terminally aligned sequences of
putative SALMFamides derived from the L-type SALMFamide precursors in Sp, Aj and Pm. Hydrophobic residues are shown in red, hydrophilic
residues are shown in green and basic residues are shown in pink. The putative C-terminal amide group is denoted as ‘‘a’’.
doi:10.1371/journal.pone.0059076.g005
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Functional Significance of the Discovery that in the
Starfish P. miniata S1 is Derived from a Precursor that
Comprises Six Other L-type SALMFamides
The L-type SALMFamide precursor identified here in P. miniata
is noteworthy by comparison with the L-type SALMFamide
precursors in A. japonicus and S. purpuratus because it comprises
more putative neuropeptides. Thus, in addition to S1, there are six
other putative L-type neuropeptides. Evidence that multiple L-
type SALMFamides exist in starfish has, however, been reported
previously [20]. Whilst only S1 and S2 were isolated from A. rubens
and A. forbesi, when extracts of radial nerve cords from M. glacialis
were analysed using HPLC and radioimmunoassays employing
antibodies to S1 and S2, other L-type peptides were discovered. In
addition to S1, which has thus far been found in all starfish species
analysed [7,20], three other peptides were isolated from M.
glacialis: an S2-like peptide (SGPYSMTSGLTFamide; MagS2),
Mag S3 (AYHSALPFamide) and MagS4 (AYQTGLPFamide)
[20]. With the identification of a gene encoding the L-type
SALMFamide precursor in P. miniata it is evident that the M.
glacialis neuropeptides MagS3 and MagS4 are similar to two of the
L-type SALMFamides in P. miniata: AFHSALPFamide and
GYHTGLPFamide, respectively. Furthermore, in addition to
these two peptides, there are three other putative neuropeptides
derived from the P. miniata L-type SALMFamide precursor that
have the C-terminal motif LPFamide. Lastly, there is also an N-
terminally extended putative L-type neuropeptide with two proline
residues (PAGSPVFHSALTYamide).
Investigation of the physiological roles of S1 in starfish has
revealed that this peptide has inhibitory actions. Thus, it causes
relaxation of three preparations from A. rubens: the cardiac
stomach, tube feet and apical muscle [9,10]. In addition,
experimental studies on the starfish Asterina pectinifera have revealed
that S1 causes inhibition of potassium-induced release of gonad-
stimulating hormone from radial nerves [26]. We now know,
however, based on analysis of P. miniata genome sequence data,
that S1 is co-synthesized and presumably co-released with six
other L-type SALMFamides. This therefore raises questions with
regard to the actions of these other L-type SALMFamides. Do
they, like S1, also have inhibitory actions? Preliminary data
obtained from experiments testing the effects of the M. glacialis L-
type SALMFamide MagS3 on cardiac stomach preparations from
A. rubens have revealed that, like S1, it causes relaxation of the
cardiac stomach. However, when tested at a concentration of
1 mM MagS3 was less effective than S1 as a muscle relaxant in A.
rubens [20]. Clearly, to gain a deeper insight on the functional
significance of the existence of the seven L-type SALMFamides
derived from the P. miniata L-type precursor, further experimental
studies will now need to be conducted, testing and comparing the
effects of all seven peptides on preparations from P. miniata.
Functional Significance of the Discovery of an F-type
SALMFamide Precursor in P. miniata
F-type SALMFamides with the C-terminal motif FxFamide
(GYSPFMFamide and FKSPFMFamide) were first isolated from
the sea cucumber A. japonicus on account of their relaxing actions
on muscle preparations [16]. We now know that these two
peptides are derived from an F-type SALMFamide precursor that
comprises other F-type SALMFamides and three L-type or L-type-
like SALMFamides ([19]; Figure 4C). Furthermore, the identifi-
cation of an F-type SALMFamide precursor in the sea urchin S.
purpuratus revealed that F-type SALMFamides are not only found
in holothurians but also occur in their sister group – the echinoids
[17]. With the identification of an F-type SALMFamide precursor
in the starfish P. miniata, it has been established that the
phylogenetic distribution of F-type SALMFamides extends to the
asteroids and therefore their evolutionary origin can be traced
back at least as far as the common ancestor of echinoids,
holothurians and asteroids. However, nothing is known about the
pharmacological actions and physiological roles of F-type
SALMFamides in starfish or in sea urchins. Based on what is
known about the pharmacological effects of F-type SALMFamides
as muscle relaxants in sea cucumbers [16], it seems likely that F-
type SALMFamides also have inhibitory effects in starfish and sea
urchins. However, it remains to be determined what is the
physiological relevance of the existence of two types of
SALMFamides (L-type and F-type) in echinoderms. Are they
expressed by distinct or overlapping populations of neurons?
Indirect evidence from immunocytochemical studies [12,13]
suggests that L-type and F-type SALMFamide precursor genes
are expressed by different populations of neurons in starfish, as
discussed below. However, definitive investigation of this issue will
require analysis using double-labelling mRNA in situ hybridisation
techniques.
Lastly, nothing is known about the receptor(s) that mediate the
effects of SALMFamides in echinoderms. Do F-type SALMFa-
mides and L-type SALMFamides exert effects by binding to
different receptor types? With the growing body of genomic/
transcriptomic sequence data obtained from several echinoderm
species it may now be possible to address this issue, probably by
working with the assumption that SALMFamide receptors are
likely to be G-protein coupled receptors.
Functional Significance of the Discovery that an S2-like
Peptide is Derived from an F-type SALMFamide Precursor
in P. miniata
S1 (GFNSALMFamide) and S2 (SGPYSFNSGLTFamide)
share the C-terminal sequence FNSxLxFamide (where x is
variable), and therefore it was proposed that S1 and S2 may have
arisen through processes of intragenic or gene duplication followed
by sequence divergence [6]. With the development of antibodies to
S1 and S2 it became possible to investigate the expression of these
two peptides in starfish. Interestingly, whilst the overall tissue/
organ distribution of S1 and S2 is very similar, at the cellular/sub-
cellular level double-labelling immunocytochemistry revealed that
S1 and S2 appear to be expressed by different populations of
neurons [12,13]. Therefore, these data indicated that S1 and S2
are not derived from the same precursor but are derived either
from alternatively spliced products of the same gene or from
products of two different genes. With the identification of
SALMFamide genes in P. miniata we now know that S1 and the
Figure 6. Comparative analysis of F-type SALMFamide precursors and putative SALMFamides derived from F-type SALMFamide
precursors. A. Multiple sequence alignment of F-type SALMFamide precursors from Strongylocentrotus purpuratus (Sp), Apostichopus japonicus (Aj)
and Patiria miniata (Pm). The symbol * labels the positions of residues that are identical in all three sequences, whilst the symbols : and. label the
positions of strongly and weakly conserved residues, respectively. Putative neuropeptides that are aligned in all three sequences or that are aligned
in the Pm sequence and the Sp or Aj sequences are labelled: Align F1– AlignF7. B. Comparison of the C-terminally aligned sequences of putative
SALMFamides derived from the F-type SALMFamide precursors in Sp, Aj and Pm. Hydrophobic residues are shown in red, hydrophilic residues are
shown in green, acidic residues are shown in blue and basic residues are shown in pink. The putative C-terminal amide group is denoted as ‘‘a’’.
doi:10.1371/journal.pone.0059076.g006
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S2-like peptide SNGPYSMSGLRSLTFamide are encoded by
different genes, with S1 being one of seven putative neuropeptide
products of the L-type SALMFamide precursor and the S2-like
peptide being the one and only L-type peptide that is derived from
the F-type SALMFamide precursor in this species. Accordingly, it
seems likely that in Asterias rubens and Asterias forbesi S1 is derived
from a L-type SALMFamide precursor and S2 is derived from an
F-type SALMFamide precursor. This is interesting from a func-
tional perspective because S1 and S2 share the common C-
terminal motif FNSxLxFamide (where x is variable). Therefore,
this suggests that peptides (S1 and S2) derived from different
SALMFamide precursors may have acquired a common motif by
convergent molecular evolution. Furthermore, it is noteworthy
that S2 is more potent/effective than S1 as a muscle relaxant in
starfish [9,10,15]. What might be the functional significance of
this? A clue may be found in the observation that S2, but not S1,
can be detected by radioimmunoassay in the perivisceral coelomic
fluid of the starfish Asterias rubens [11]. This suggests that S2 may
act as a hormone in starfish, which may also explain why S2 is
more potent than S1. In this context, the discovery that an S2-like
peptide is derived from the F-type SALMFamide precursor in P.
miniata is intriguing. Thus, do F-type SALMFamides act as
hormones in starfish? Furthermore, is the occurrence of L-type
SALMFamides in F-type SALMFamide precursors a feature that
enables convergent activation of L-type SALMFamide receptors
by peptides derived from different precursors and acting via
different signalling pathways: i.e. hormonal (S2 or S2-like) versus
non-hormonal (S1). Clearly, these are speculative hypotheses that
will require detailed experimental analysis. However, they provide
a framework for investigation of the physiological relevance of the
occurrence of L-type SALMFamides in F-type SALMFamide
precursors.
The Physiological Significance of Neuropeptide
‘‘Cocktails’’ Derived from the Same Precursor: the
SALMFamides as a Model Experimental System
The identification of SALMFamide genes in echinoderms has
revealed a remarkable diversity of SALMFamide neuropeptides in
each species. Thus in starfish, from the original biochemical
identification of two SALMFamides (S1 and S2) in Asterias we have
progressed to the discovery of sixteen putative SALMFamides in P.
miniata based on analysis of the sequences of its two SALMFamide
genes. But what is the physiological significance of the multiple
neuropeptides that are derived from each of the two SALMFa-
mide precursors? This is a question that remains largely un-
resolved, not only for SALMFamide precursors in echinoderms
but for neuropeptide precursors in general. The occurrence of
neuropeptide precursors comprising multiple isoforms of a partic-
ular neuropeptide type is a common phenomenon, particularly in
invertebrates [4,27,28]. Furthermore, its physiological relevance
has been investigated, most notably in model invertebrates such as
Drosophila melanogaster. For example, the actions of eight FMRFa-
mide-related neuropeptides that are derived from the same
precursor were examined by testing and comparing their effects
on nerve-stimulated contraction of larval body-wall muscles [29].
Seven of the peptides strongly enhanced twitch tension and one of
the peptides was inactive. The potency and efficacy of the seven
active peptides were similar and when the peptides were tested in
combination at ratios corresponding to copy number in the
precursor protein, their effects were additive and there was no
evidence of higher-order interactions among them. It was
concluded, therefore, that with respect to effects on nerve-
stimulated contraction of Drosophila larval body-wall muscles the
seven active peptides exhibit functional redundancy. However, the
authors of this study cautiously highlight the need to ‘‘search for
additional functions or processes in which these peptides may act
differentially’’ [29].
Evidence that structurally-related neuropeptides derived from
the same precursors are not simply functionally redundant
isoforms has been provided by detailed analysis of genome
sequence data comparing the neuropeptidome of twelve species
belonging to the genus Drosophila, the common ancestor of which is
estimated to date back 40–60 million years. Remarkably, the
neuropeptidome was found to be identical in all twelve Drosophila
species [30]. This finding indicates that the multiple isoforms of
neuropeptides derived from the same precursor are under
stabilizing selection and therefore are unlikely to be functionally
redundant. These important findings from comparative genomic
analyses highlight the need now to investigate and compare in
greater detail the pharmacological actions and physiological roles
of neuropeptide isoforms derived from the same precursor protein.
Our discovery of SALMFamide genes in echinoderms has
highlighted new model systems in which the physiological
relevance of structurally related neuropeptide isoforms derived
from the same precursor could be investigated. Of particular
interest in this regard are the F-type SALMFamide precursors in
the sea cucumber A. japonicus and the starfish P. miniata, which
largely comprise F-type or F-type-like SALMFamides but which
also contain one or more L-type SALMFamides. The functional
significance of these neuropeptide ‘‘cocktails’’ could be investigat-
ed using established in vitro and in vivo assays [9,10].
Concluding Comments
The data presented in this paper have provided new insights on
the evolution and diversity of SALMFamide neuropeptides in the
Phylum Echinodermata and further insights will be obtained when
genome and/or neural transcriptome data are available for
ophiuroid and crinoid species. However, currently nothing is
known about relationships between SALMFamide neuropeptides
in echinoderms and neuropeptides in other phyla. Do SALMFa-
mide neuropeptides also exist in hemichordates, a sister phylum to
the echinoderms? Genome sequence data are available for the
hemichordate species Saccoglossus kowalevskii (https://www.hgsc.
bcm.edu/content/acorn-worm-genome-project) but thus far our
analysis of these data has not revealed genes encoding peptides
that resemble SALMFamide neuropeptides. If the receptors that
mediate the effects of SALMFamide neuropeptides in echino-
derms can be identified, then this may reveal relationships
between SALMFamides and neuropeptides in other phyla.
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